Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
STIP1 homology and U-box containing protein 1 (abbreviated as STUB1, commonly known as CHIP) is an E3 ubiquitin-protein ligase involved in the cellular protein quality control system. CHIP functions as a co-chaperone by binding to heat shock proteins (HSP70/HSC70/HSP90), inhibiting their ATPase activity, and channeling damaged, misfolded, or surplus proteins toward ubiquitin-mediated proteasomal degradation. Structurally, CHIP contains an N-terminal TPR (tetratricopeptide repeat) domain for chaperone interaction, a central coiled-coil domain, and a C-terminal U-box domain conferring E3 ligase enzymatic activity. STUB1/CHIP plays central roles in maintaining proteostasis, especially under stress, and regulates key processes such as autophagy, apoptosis, cell proliferation, and signal transduction by controlling the turnover of receptors and transcription factors. Mutations in STUB1 cause autosomal dominant spinocerebellar ataxia type 48 (SCA48) and recessive ataxia SCAR16 due to loss of CHIP function and impaired neuronal protein homeostasis. CHIP is linked to multiple neurodegenerative and neoplastic conditions and is of emerging interest as a therapeutic target and biomarker for diseases involving protein aggregation and dysregulated degradation.
Promotes ubiquitination and proteasomal degradation of misfolded, damaged, or excess client proteins (including tau, α-synuclein, p53, ErbB2, androgen receptor). E3 ligase activity depends on its U-box domain and interaction with E2 ubiquitin-conjugating enzymes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on STIP1 homology and U-box containing protein 1 (STUB1).